×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
上海药物研究所 [73]
复旦大学上海医学院 [25]
北京大学 [24]
山东大学 [22]
中国医学科学院 北... [17]
厦门大学 [16]
更多...
内容类型
期刊论文 [376]
学位论文 [21]
会议论文 [13]
专利 [7]
SCI/SSCI论文 [2]
其他 [2]
更多...
发表日期
2023 [4]
2022 [5]
2021 [12]
2020 [24]
2019 [28]
2018 [49]
更多...
学科主题
Plant Scie... [8]
Pharmacolo... [4]
plant scie... [3]
Agronomy [2]
Chemistry [2]
Food Scien... [2]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共422条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
提交时间升序
提交时间降序
题名升序
题名降序
作者升序
作者降序
JC-010a, a novel selective SHP2 allosteric inhibitor, overcomes RTK/non-RTK-mediated drug resistance in multiple oncogene-addicted cancers
期刊论文
CANCER LETTERS, 2024, 卷号: 582, 页码: 15
作者:
Lu, Xuxiu
;
Yu, Rilei
;
Li, Zhen
;
Yang, Mengke
;
Dai, Jiajia
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2024/04/07
Acquired resistance
Cancer
NSCLC
JC-010a
SHP2
Catalytic oxidation properties of 3D printed ceramics with Bouligand structures
期刊论文
Chemical Engineering Journal, 2023, 卷号: 474, 期号: 无, 页码: 145504
作者:
Xu X(徐昕)
;
He B(何波)
;
Wang YX(汪祎贤)
;
Xi YT(席云泰)
;
Liu DS(刘德胜)
收藏
  |  
浏览/下载:137/0
  |  
提交时间:2023/10/31
Bioinspired structural design
3D printing
Bouligand structure
Helicoidal catalytic ceramics
VOCs catalytic oxidation
Predicting and overcoming resistance to CDK9 inhibitors for cancer therapy
期刊论文
ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13
作者:
Hua, Chen
;
Shena, Lijuan
;
Zoua, Fengming
;
Wua, Yun
;
Wanga, Beilei
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2023/11/10
Acquired resistance mutations
CDK9 inhibitors
Transcription
Single nucleotide polymorphisms
BAY1251152
Catalytic oxidation properties of 3D printed ceramics with Bouligand structures
期刊论文
Chemical Engineering Journal, 2023, 期号: 474, 页码: 145504
作者:
Xin Xu
;
Bo He
;
Yixian Wang
;
Yuntai Xi
;
Desheng Liu
收藏
  |  
浏览/下载:56/0
  |  
提交时间:2024/01/02
Bioinspired structural design
3D printing
Bouligand structure
Helicoidal catalytic ceramics
VOCs catalytic oxidation
Design and Application of a Deep-Sea Engineering Geology In Situ Test System
期刊论文
MINERALS, 2023, 卷号: 13, 期号: 2, 页码: 1
作者:
Zhong, Kaiming
;
Chen, Ming
;
Xie, Chao
;
Zheng, Jinrong
;
Chen, Wei
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2023/04/14
sediment
in situ test
cone resistance
sleeve friction
pore pressure
shear resistance
Eslami-Fellenius soil classification map
Targeting KRAS mutant cancers: from druggable therapy to drug resistance
期刊论文
MOLECULAR CANCER, 2022, 卷号: 21
作者:
Zhu, Chunxiao
;
Guan, Xiaoqing
;
Zhang, Xinuo
;
Luan, Xin
;
Song, Zhengbo
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2022/12/23
KRAS mutations
Druggable
Resistance
Combination therapy
Impact of clinical and molecular features on efficacy and outcome of patients with non-small cell lung cancer receiving second-line osimertinib
期刊论文
BMC CANCER, 2022, 卷号: 22
作者:
Jin, Ying
;
Lin, Chen
;
Shi, Xun
;
He, Qiong
;
Yan, Junrong
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2022/12/23
Clinical and molecular features
Efficacy and outcome
EGFR T790M mutation
Non-small-cell lung cancer
Osimertinib
Disease progression patterns and molecular resistance mechanisms to crizotinib of lung adenocarcinoma harboring ROS1 rearrangements
期刊论文
NPJ PRECISION ONCOLOGY, 2022, 卷号: 6
作者:
Zhang, Yongchang
;
Huang, Zhe
;
Zeng, Liang
;
Zhang, Xiangyu
;
Li, Yizhi
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2022/05/05
CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancers
期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:
Cao, Jiang-yan
;
Qi, Shuang
;
Wu, Hong
;
Wang, Ao-li
;
Liu, Qing-wang
收藏
  |  
浏览/下载:90/0
  |  
提交时间:2022/03/28
HER2
breast cancers
gastric cancers
irreversible inhibitor
drug resistance
The Cycas genome and the early evolution of seed plants
期刊论文
NATURE PLANTS, 2022, 卷号: 8, 期号: 4, 页码: 389+
作者:
Liu, Yang
;
Wang, Sibo
;
Li, Linzhou
;
Yang, Ting
;
Dong, Shanshan
收藏
  |  
浏览/下载:0/0
  |  
提交时间:2024/03/07
©版权所有 ©2017 CSpace - Powered by
CSpace